High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing.
Times cited: 370
Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling.
Journal of Clinical Oncology.
Times cited: 678